Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Bayer and Interferon beta-1b

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Bayer and Interferon beta-1b

Bayer vs. Interferon beta-1b

Bayer AG is a German multinational, pharmaceutical and life sciences company. Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS).

Similarities between Bayer and Interferon beta-1b

Bayer and Interferon beta-1b have 4 things in common (in Unionpedia): Bayer, Glatiramer acetate, Multiple sclerosis, Schering AG.

Bayer

Bayer AG is a German multinational, pharmaceutical and life sciences company.

Bayer and Bayer · Bayer and Interferon beta-1b · See more »

Glatiramer acetate

Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone) is an immunomodulator medication currently used to treat multiple sclerosis.

Bayer and Glatiramer acetate · Glatiramer acetate and Interferon beta-1b · See more »

Multiple sclerosis

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged.

Bayer and Multiple sclerosis · Interferon beta-1b and Multiple sclerosis · See more »

Schering AG

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006.

Bayer and Schering AG · Interferon beta-1b and Schering AG · See more »

The list above answers the following questions

Bayer and Interferon beta-1b Comparison

Bayer has 223 relations, while Interferon beta-1b has 36. As they have in common 4, the Jaccard index is 1.54% = 4 / (223 + 36).

References

This article shows the relationship between Bayer and Interferon beta-1b. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »